Mayer Schreiber, CEO of Discovery Park, and Chris Broom, Head of Business Development at Discovery Park, recently attended the JP Morgan Healthcare Conference in San Francisco to build global connections and raise awareness of the opportunities in the UK for the biotech industry, as well as exploring opportunities for Discovery Park Ventures and its portfolio companies. The conference brought together thousands of industry experts from across the globe to discuss the biggest challenges and opportunities for 2024 and beyond.
News
MedFlow Clinical has been recognised as a global top 10 clinical trial supply company by Life Sciences Review. Read the full story...
MedFlow Clinical: Revolutionising Clinical Trial Supply Management
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has heralded the start of its next successful phase with four promotions and eight new arrivals.
Dr Shailendra Singh, CEO of Cellomatics Biosciences, comments: “Capitalising on our existing strengths and internal team expertise, we intend to further consolidate our position as a specialist biology CRO by broadening and deepening our service offerings in 2024. With these new appointments and internal restructuring, we are poised to catapult ourselves to the next phase of our growth journey.”
Check out the Bristows Biotech Review of the Year. This report reflects on the key developments in the biotech industry, including:
- Legal updates
- Generative AI
- The Unified Patent Court
- CRISPR technology
- Predictions for 2024
Creative Places enters new era with the appointment of new partner and the retirement of co-founder
Seb Denby is promoted to Partner as co-founder Jonathan Burroughs retires
16th January 2024: Creative Places, a leading R&D real estate advisor, announces the promotion of Seb Denby to Partner and the retirement of its co-founder and former CEO, Jonathan Burroughs.
Sandwich, Kent, UK, 17th January 2023 / Sciad Newswire / Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly. Vox Imaging is the eighth investment from DPV’s first fund.
As the life sciences sector continues to evolve at a rapid pace, Biocair, a leading global life science logistics expert, stands at the forefront of industry excellence and customer service. Manish Joshi, Biocair’s Chief Commercial Officer, gives us insight into how Biocair is staying ahead of trends that will shape the industry in 2024.
Sustainability revolutionizing the life sciences supply chain
Enter our competition for a chance to win a place on a concentrated three-day bootcamp in Boston with boardroom-style sessions, led by top life science businesses in the Greater Boston cluster, aimed at providing a focused ‘Getting US-ready’ experience. Whether you are looking to enter the US market for investment, collaborations or clients, this is a brilliant opportunity to embark on a journey to elevate your business to the next level.
CELLBANKER® freezing media from AMSBIO is now available in customizable formats, seamlessly integrating into cell manufacturing processes with personalized formulations, volumes, and packaging.
Cited in over 500 scientific publications, the CELLBANKER range has proven itself as a safe and reliable solution for storing cells and tissues. This includes GMP-grade, chemically defined formulations specifically designed for the storage of biospecimens for clinical applications.